www.fdanews.com/articles/130730-astrazeneca-to-start-long-term-brilinta-heart-attack-study

AstraZeneca to Start Long-Term Brilinta Heart Attack Study

October 1, 2010

AstraZeneca Plc plans to see if its new blood-thinning drug Brilinta improves the health of heart attack patients up to three years later.
Bloomberg